{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:18Z","timestamp":1761513618256},"reference-count":57,"publisher":"Baishideng Publishing Group Inc.","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2015]]},"DOI":"10.3748\/wjg.v21.i14.4126","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T03:01:37Z","timestamp":1429239697000},"page":"4126","source":"Crossref","is-referenced-by-count":5,"title":["Thalidomide ameliorates portal hypertension<i>via<\/i>nitric oxide synthase independent reduced systolic blood pressure"],"prefix":"10.3748","volume":"21","author":[{"given":"Nicholas G","family":"Theodorakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5442"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.007"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:G52-G57.","DOI":"10.1152\/ajpgi.1983.244.1.G52"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i11.1707"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/203794"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12357"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701220"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00003.2013"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmann JV. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 2003;124:1500-1508.","DOI":"10.1016\/S0016-5085(03)00280-4"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998;114:344-351.","DOI":"10.1016\/S0016-5085(98)70487-1"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996;25:370-378.","DOI":"10.1016\/S0168-8278(96)80124-3"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wiest R, Shah V, Sessa WC, Groszmann RJ. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999;276:G1043-G1051.","DOI":"10.1152\/ajpgi.1999.276.4.G1043"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.003764"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nm1289"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.320465"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.521203"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kaviani A, Ohta M, Itani R, Sander F, Tarnawski AS, Sarfeh IJ. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J Gastrointest Surg 1997;1:371-376.","DOI":"10.1016\/S1091-255X(97)80059-5"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Paz Y, Frolkis I, Pevni D, Shapira I, Yuhas Y, Iaina A, Wollman Y, Chernichovski T, Nesher N, Locker C. Effect of tumor necrosis factor-alpha on endothelial and inducible nitric oxide synthase messenger ribonucleic acid expression and nitric oxide synthesis in ischemic and nonischemic isolated rat heart. J Am Coll Cardiol 2003;42:1299-1305.","DOI":"10.1016\/S0735-1097(03)00992-6"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993;177:1675-1680.","DOI":"10.1084\/jem.177.6.1675"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230644"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Soupison T, Yang S, Bernard C, Moreau R, Kirstetter P, D&rsquo;Almeida M, Cailmail S, Tedgui A, Lebrec D. Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis. Clin Sci (Lond) 1996;91:29-33.","DOI":"10.1042\/cs0910029"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Austin AS, Mahida YR, Clarke D, Ryder SD, Freeman JG. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis. Aliment Pharmacol Ther 2004;19:79-88.","DOI":"10.1046\/j.1365-2036.2003.01809.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995;92:10688-10692.","DOI":"10.1073\/pnas.92.23.10688"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996;93:13176-13181.","DOI":"10.1073\/pnas.93.23.13176"},{"key":"ref25","unstructured":"Golikov PP, Nikolaeva NIu. [Analysis of nitrites\/nitrates (NOx) in serum]. Biomed Khim 2004;50:79-85."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2007.12.014"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Malleo G, Mazzon E, Genovese T, Di Paola R, Mui&agrave; C, Crisafulli C, Siriwardena AK, Cuzzocrea S. Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock 2008;29:89-97.","DOI":"10.1097\/shk.0b013e318067df68"},{"key":"ref28","unstructured":"Mazzon E, Mui&agrave; C, Di Paola R, Genovese T, De Sarro A, Cuzzocrea S. Thalidomide treatment reduces colon injury induced by experimental colitis. Shock 2005;23:556-564."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gcb.2008.03.012"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Wang JJ, Gao GW, Gao RZ, Liu CA, Ding X, Yao ZX. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. World J Gastroenterol 2004;10:689-693.","DOI":"10.3748\/wjg.v10.i5.689"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001;89:273-293.","DOI":"10.1016\/S0163-7258(01)00128-0"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000078606.59842.01"},{"key":"ref33","unstructured":"Park E, Levis WR, Greig N, Jung E, Schuller-Levis G. Effect of thalidomide on nitric oxide production in lipopolysaccharide-activated RAW 264.7 cells. J Drugs Dermatol 2010;9:330-333."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0b013e31815d0780"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2014.02.006"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073562"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2013.05.018"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5047-06.2007"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.04.039"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2914-0"},{"key":"ref41","unstructured":"Reichen J. Portal hypertension: cytokines and endothelins. Hepatogastroenterology 1999;46 Suppl 2:1434-1436."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2006.09.006"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.12.043"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Aukrust P, Yndestad A, Dam\u00e5s JK, Ueland T, &Oslash;ie E, Gullestad L. Potential mechanisms of benefit with thalidomide in chronic heart failure. Am J Cardiovasc Drugs 2007;7:127-134.","DOI":"10.2165\/00129784-200707020-00004"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Gullestad L, Semb AG, Holt E, Sk\u00e5rdal R, Ueland T, Yndestad A, Fr&oslash;land SS, Aukrust P. Effect of thalidomide in patients with chronic heart failure. Am Heart J 2002;144:847-850.","DOI":"10.1067\/mhj.2002.125628"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn287"},{"key":"ref47","unstructured":"Zhang SZ, Li MT, He JG, Zeng XF. [Effects of three immunosuppressive agents and simvastatin on cell-proliferation and endothelin secretion of human endothelial cells]. Zhonghua Neike Zazhi 2008;47:495-498."},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Mitaka C, Hirata Y, Ichikawa K, Yokoyama K, Emori T, Kanno K, Amaha K. Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. Am J Physiol 1994;267:H1530-H1536.","DOI":"10.1152\/ajpheart.1994.267.4.H1530"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Osiovich H, Goldberg RN, Suguihara C, Adams JA, Martinez O, Kuo G, Feuer WI, Offenbacher S, Bancalari E. Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. Biol Neonate 1995;68:342-353.","DOI":"10.1159\/000244255"},{"key":"ref50","unstructured":"Theodorakis NG, Wang YN, Wu J, Maluccio MA, Skill NJ. Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension. Int J Physiol Pathophysiol Pharmacol 2010;2:104-110."},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Cavo M, Zamagni E, Cellini C, Tosi P, Cangini D, Cini M, Valdr&egrave; L, Palareti G, Masini L, Tura S. Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy. Blood 2002;100:2272-2273.","DOI":"10.1182\/blood-2002-06-1674"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Niwayama S, Loh C, Turk BE, Liu JO, Miyachi H, Hashimoto Y. Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action. Bioorg Med Chem Lett 1998;8:1071-1076.","DOI":"10.1016\/S0960-894X(98)00171-1"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S1726-4901(09)70063-2"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.01.160"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.04.002"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25625"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.01983.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i14\/4126.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T08:07:22Z","timestamp":1651738042000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v21\/i14\/4126.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":57,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v21.i14.4126","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}